Press release
Driving Intratumoral Cancer Therapies Market Growth in 2025: The Role of Rising Cancer Incidence Fuels Expansion Of Intratumoral Cancer Therapies Market
Intratumoral Cancer Therapies Market Size
Intratumoral Cancer Therapies Market Size Growth Forecast: What to Expect by 2025?
The market size of intratumoral cancer therapies has seen notable development in the last few years. The market size will increase from $140 billion in 2024 to $158.38 billion in 2025, boasting a compound annual growth rate (CAGR) of 13.1%. Reasons for the expansion during the historical period involve progress in cancer studies, a rise in cancer prevalence, the need for precise medicine, documented clinical proof and research efforts, along with unfulfilled medical requirements.
How Will the Intratumoral Cancer Therapies Market Size Evolve and Grow by 2029?
The market size for intratumoral cancer treatments is projected to experience significant expansion in the coming years, reaching $248.42 billion by 2029 with a compound annual growth rate (CAGR) of 11.9%. This anticipated growth in the forecast period can be attributed to several factors. These include developments in immunotherapy, rising adoption of precision medicine, expanding clinical trials, increased focus on rare cancer types, and regulatory support and approvals. Key trends predicted for the forecast period involve exploration of intratumoral immunomodulators, incorporating image-guided treatments, using hyperthermia in intratumoral treatments, clinical trials for combination treatments, and regulatory endorsement for intratumoral therapies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report
What Drivers Are Propelling the Growth of Intratumoral Cancer Therapies Market Forward?
The escalation in cancer occurrences is projected to fuel the expansion of the intratumoral cancer therapies market in the future. Cancer is a collective term for ailments typified by rampant growth and dispersion of atypical cells within the body. Intratumoral cancer therapies, used in the detection and treatment of cancer, aid in circumventing off-target toxicities, dose-restrictive toxicities, and negative effects due to immune provocation in cancer patients. For instance, as per data from the American Cancer Society, a non-profit cancer advocacy organization located in the US, there was a rise in cancer cases to 1,958,310 in January 2023, marking a 3.16% increase from 1,898,160 in 2021. Consequently, the rising incidence of cancer is stimulating the expansion of the intratumoral cancer therapies market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9979&type=smp
Which Emerging Trends Are Transforming the Intratumoral Cancer Therapies Market in 2025?
The march of technology is a predominant trend emerging in the intratumoral cancer therapies market. Firms in this sector are emulating new technologies to maintain their market standing. In March 2022, for example, Evonik, a US firm specializing in the production of specialty chemicals, unveiled a cutting-edge microparticle technology called EUDRATEC SoluFlow. This technology is designed to enhance the solubility of active pharmaceutical ingredients in oral drug formulations used in cancer treatments. This breakthrough technology allows the use of chemicals previously considered insoluble, opening the door to a more diverse range of oral medications.
What Are the Key Segments in the Intratumoral Cancer Therapies Market?
The intratumoral cancer therapies market covered in this report is segmented -
1) By Technology: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines
2) By Application: Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head And Neck Cancer, Other Applications
3) By End Users: Hospitals, Cancer Research Centers, Clinics
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
3) By Checkpoint Inhibitors: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Cell Therapies: CAR T-Cell Therapy, TCR Therapy
5) By Immune System Modulators: Immune Checkpoint Inhibitors, Toll-Like Receptor Agonists
6) By Adoptive Cell Transfer: Tumor-Infiltrating Lymphocytes (TILs), Peripheral Blood Lymphocytes (PBLs)
7) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factor (TNF)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9979&type=smp
Who Are the Key Players Shaping the Intratumoral Cancer Therapies Market's Competitive Landscape?
Major companies operating in the intratumoral cancer therapies market include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc., Novartis AG, Johnson & Johnson, Eli Lilly and Company, F. Hoffmann-la Roche, Takeda Pharmaceutical Company Ltd., GSK plc, Ziopharm Oncology Inc., Celldex Therapeutics Inc., Astellas Pharma Inc., Sirnaomics, Checkmate Pharmaceuticals Inc., Immunovative Therapies Ltd., Idera Pharmaceuticals Inc., Daiichi Sankyo, Philogen S.p.A., Apexigen Inc., Merck Group, OncoSec Medical Incorporated, DNAtrix, Istari Oncology Inc., Nanobiotix, Exicure Inc., Karyopharm Therapeutics Inc., Dechra Pharmaceuticals PLC, Torigen Pharmaceuticals Inc., Elekta, Virbac, Norbrook Laboratories, Regeneus Ltd., QBiotics Group, VetDC
What Geographic Markets Are Powering Growth in the Intratumoral Cancer Therapies Market?
North America was the largest region in the intratumoral cancer therapies market in 2024. The regions covered in the intratumoral cancer therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9979
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Driving Intratumoral Cancer Therapies Market Growth in 2025: The Role of Rising Cancer Incidence Fuels Expansion Of Intratumoral Cancer Therapies Market here
News-ID: 4089237 • Views: …
More Releases from The Business Research Company
Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…
Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…
Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…
Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
